4//SEC Filing
GRAHAM GINGER L 4
Accession 0001209191-19-056640
CIK 0001131324other
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 9:44 PM ET
Size
30.2 KB
Accession
0001209191-19-056640
Insider Transaction Report
Form 4
GRAHAM GINGER L
Director
Transactions
- Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−8,250→ 0 totalExercise: $35.87From: 2014-06-07Exp: 2023-06-07→ Common Stock (8,250 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−1,515→ 0 totalExercise: $36.04From: 2014-06-07Exp: 2023-06-07→ Common Stock (1,515 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−10,000→ 0 totalExercise: $26.01From: 2016-06-12Exp: 2026-06-12→ Common Stock (10,000 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−10,000→ 0 totalExercise: $26.18From: 2017-06-10Exp: 2026-06-10→ Common Stock (10,000 underlying) - Disposition to Issuer
Common Stock
2019-11-08−955→ 0 total(indirect: By Trust) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−10,000→ 0 totalExercise: $27.75From: 2015-06-06Exp: 2024-06-06→ Common Stock (10,000 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−10,000→ 0 totalExercise: $51.72From: 2019-06-07Exp: 2028-06-07→ Common Stock (10,000 underlying) - Disposition to Issuer
Common Stock
2019-11-08−52,349→ 955 total(indirect: By Trust) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−8,250→ 0 totalExercise: $34.44From: 2013-06-08Exp: 2022-06-08→ Common Stock (8,250 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−10,000→ 0 totalExercise: $31.53From: 2018-06-16Exp: 2027-06-16→ Common Stock (10,000 underlying) - Disposition to Issuer
Director Stock Option (right to buy)
2019-11-08−6,583→ 0 totalExercise: $52.41From: 2020-06-14Exp: 2029-06-14→ Common Stock (6,583 underlying)
Footnotes (11)
- [F1]Disposed of in connection with the acquisition of Issuer (the "Merger") by Exact Sciences Corporation ("Exact Sciences") pursuant to the Agreement and Plan of Merger, dated July 28, 2019 (the "Merger Agreement"), among Exact Sciences, Spring Acquisition Corp., and Issuer, whereby such shares of Issuer common stock were cancelled and converted into the right to receive a cash payment of $1,439,646 and 23,579 shares of Exact Sciences common stock, having a market value of $79.95 per share, based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F10]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $62,196 and 1,018 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F11]Disposed of in connection with the Merger, whereby such Issuer restricted stock unit award, whether or not vested, was cancelled in exchange for a cash payment of $39,074 and 640 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019. Pursuant to the applicable option award agreement, 100% of the unvested options held by the Reporting Person became fully vested following the change in control of the Issuer effected by the Merger.
- [F2]Disposed of in connection with the Merger, whereby such Issuer restricted stock unit award, whether or not vested, was cancelled in exchange for a cash payment of $26,277 and 430 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F3]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $109,968 and 1,801 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F4]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $105,114 and 1,721 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F5]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $19,197 and 314 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F6]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $160,821 and 2,634 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F7]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $167,981 and 2,751 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F8]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $167,281 and 2,739 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
- [F9]Disposed of in connection with the Merger, whereby such Issuer stock option was cancelled in exchange for a cash payment of $145,268 and 2,379 shares of Exact Sciences common stock, having a market value of $79.95 per share based on the closing price of Exact Sciences common stock on November 7, 2019.
Documents
Issuer
GENOMIC HEALTH INC
CIK 0001131324
Entity typeother
Related Parties
1- filerCIK 0001192601
Filing Metadata
- Form type
- 4
- Filed
- Nov 13, 7:00 PM ET
- Accepted
- Nov 14, 9:44 PM ET
- Size
- 30.2 KB